The Gross Margin of Chengdu Easton Biopharmaceuticals Co Ltd (688513.SS) is 74.50%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 74.50% |
| 2023-12-31 | 79.78% |
| 2022-12-31 | 83.06% |
| 2021-12-31 | 85.81% |
| 2020-12-31 | 88.40% |
| 2019-12-31 | 89.94% |
| 2018-12-31 | 88.46% |
| 2017-12-31 | 84.80% |